Get the Stockscreener App
172.24
4.98%
-9.0661
Align Technology Inc stock is traded at $172.24, with a volume of 629.73K.
It is down -4.98% in the last 24 hours and down -2.53% over the past month.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
See More
Previous Close:
$181.31
Open:
$179.05
24h Volume:
629.73K
Relative Volume:
0.63
Market Cap:
$12.24B
Revenue:
$4.10B
Net Income/Loss:
$429.89M
P/E Ratio:
28.87
EPS:
5.9668
Net Cash Flow:
$583.65M
1W Performance:
-2.14%
1M Performance:
-2.53%
6M Performance:
-7.98%
1Y Performance:
+20.96%
1-Day Range:
$170.16
$181.33
1-Week Range:
$169.46
$182.20
52-Week Range:
$122.00
$200.44
Align Technology Inc Stock (ALGN) Company Profile
Name
Align Technology Inc
Sector
Industry
Phone
408-470-1000
Address
410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, CA
Compare ALGN vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALGN
Align Technology Inc
|
172.26 | 12.88B | 4.10B | 429.89M | 583.65M | 5.9668 |
ISRG
Intuitive Surgical Inc
|
390.72 | 139.37B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
182.13 | 49.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.55 | 35.89B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
220.18 | 32.38B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.84 | 31.36B | 29.14B | 1.07B | 1.05B | 1.1956 |
Align Technology Inc Stock (ALGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Buy |
| Mar-17-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-09-26 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Oct-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-14-25 | Initiated | Wells Fargo | Overweight |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Oct-10-24 | Initiated | Needham | Hold |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-11-23 | Downgrade | Goldman | Neutral → Sell |
| Oct-27-23 | Downgrade | UBS | Buy → Neutral |
| Feb-02-23 | Upgrade | Goldman | Sell → Neutral |
| Jul-28-22 | Downgrade | Goldman | Buy → Sell |
| Jan-31-22 | Initiated | Morgan Stanley | Overweight |
| Jan-31-22 | Upgrade | UBS | Neutral → Buy |
| Oct-01-21 | Resumed | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-09-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jul-08-21 | Initiated | Exane BNP Paribas | Outperform |
| Apr-22-21 | Upgrade | Berenberg | Hold → Buy |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-29-20 | Downgrade | Berenberg | Buy → Hold |
| Jul-20-20 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-09-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-24-19 | Reiterated | BofA/Merrill | Neutral |
| Oct-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-25-19 | Downgrade | Evercore ISI | Outperform → In-line |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Feb-14-19 | Downgrade | UBS | Buy → Neutral |
| Jan-17-19 | Initiated | UBS | Buy |
| Nov-20-18 | Reiterated | Credit Suisse | Outperform |
| Jul-26-18 | Reiterated | Stifel | Buy |
| Jul-13-18 | Reiterated | Stifel | Buy |
| Jun-25-18 | Resumed | BofA/Merrill | Buy |
| May-22-18 | Reiterated | Stifel | Buy |
| May-17-18 | Initiated | Evercore ISI | Outperform |
| Apr-26-18 | Reiterated | Stifel | Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Apr-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-08-18 | Initiated | Barclays | Overweight |
View All
Align Technology Inc Stock (ALGN) Latest News
How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook - TradingView
Why Align Technology (NASDAQ:ALGN) Is Back In Focus? - Kalkine Media
Align Technology: DCF Signals Overvaluation Despite Long-Term Growth Potential - Seeking Alpha
ALGN Looks 19.1% Undervalued on GF Value™ After Favorable Patent Ruling - GuruFocus
Oppenheimer Asset Management Inc. Invests $1.20 Million in Align Technology, Inc. $ALGN - MarketBeat
Align Technology, Inc. (NASDAQ:ALGN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Align Technology (ALGN) Stock Looks Cheap On Cash Flow Yet Fair On Earnings - simplywall.st
9,838 Shares in Align Technology, Inc. $ALGN Acquired by Maridea Wealth Management LLC - MarketBeat
Align Technology Inc. stock outperforms competitors on strong trading day - MarketWatch
Align Technology (ALGN) Q2 2026 Earnings Call Transcript - AOL.com
Should Investors Buy Align as Growth Meets Valuation and Demand Risks? - TradingView
A Dozen Universities Allotted Dentistry Research Grants From Align Technology - Medical Product Outsourcing
Align Appoints Noel Kilcooley as Chief Technology Officer to Support the Company's Next Phase of Growth - AOL.com
Align Technology Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
BMO Capital Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $209 - Moomoo
Angelalign Files Appeal Against Jinan Court Patent Ruling, Says No Impact on Customers - finance.biggo.com
Angelalign to appeal Align's China patent victory over clear-aligner technology - MLex
Align Technology (NASDAQ:ALGN): A Value Stock with Strong Fundamentals - ChartMill
Federal Circuit Clarifies Priority Requirements For Prior Art In Dental Monitoring SAS v. Align Technology - marketscreener.com
Align Technology Wins Patent Dispute Against Angelalign in China; Angelalign Plans to Appeal - Orthodontic Products
Align Technology, Inc. (ALGN) Stock Forecasts - Yahoo! Finance Canada
Angelaligner Will Appeal Chinese Court Decision about Premolar Extraction Solution, Which Has No Impact on Customers - Starkville Daily News
Align Technology (ALGN): Capital World Investors reports 5% beneficial stake - Stock Titan
Align Technology (ALGN) Gund-related holders report 5.4% beneficial stake - Stock Titan
Align says Chinese court ruled in its favour in Angelalign patent case - Oral Health Group
Align Technology Wins China Patent Case Against Angelalign, Angel Appeals - Medical Product Outsourcing
Federal Circuit Clarifies Priority Requirements for Prior Art in Dental Monitoring SAS v. Align Technology - Buchanan Ingersoll & Rooney PC
Align Technology Prevails in China Patent Infringement Action - marketscreener.com
Align Technology Prevails in China Patent Infringement Action Against Angelalign - Business Wire
Align Technology Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Align Names Noel Kilcooley CTO to Lead AI and Technology Strategy - citybiz
Analysts Are Bullish on These Healthcare Stocks: Gyre Therapeutics (GYRE), Align Tech (ALGN) - The Globe and Mail
Align Technology, Inc. (ALGN) - directorstalkinterviews.com
Contravisory Investment Management Inc. Makes New $1.11 Million Investment in Align Technology, Inc. $ALGN - MarketBeat
Bank of America Corp DE Lowers Holdings in Align Technology, Inc. $ALGN - MarketBeat
Align Technology Announces New Innovations to Advance Invisalign® Treatment Planning and Enhance Patient Engagement Through Its Integrated Align™ Digital Platform - AOL.com
Glenmede Trust Co. NA Lowers Position in Align Technology, Inc. $ALGN - MarketBeat
Did Align’s Expanded 2026 Buyback and Board Refresh Just Shift Align Technology's (ALGN) Investment Narrative? - simplywall.st
Align Technology, Inc. $ALGN Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Align Technology Inc (ALGN) Stock News Today - TradingKey
Align Technology Expanding its Global Operations - Medical Product Outsourcing
Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple - Seeking Alpha
Janus Henderson Group PLC Has $5.28 Million Holdings in Align Technology, Inc. $ALGN - MarketBeat
Align Technology, Inc. $ALGN Shares Sold by Royal Bank of Canada - MarketBeat
ALGN SWOT Analysis: Financial Resilience Amidst Market Challenges Revealed in 10-Q Filing - GuruFocus
Cetera Investment Advisers Acquires 9,188 Shares of Align Technology, Inc. $ALGN - MarketBeat
Align Technology Inc (ALGN) Stock Down 3.2% -- Now Undervalued? GF Score: 89/100 - GuruFocus
Align Technology Inc. stock underperforms Thursday when compared to competitors - MarketWatch
FMR LLC discloses 5.7% Align Technology (ALGN) holding in Schedule 13G - Stock Titan
ALIGN TECHNOLOGY INC 2026: Revenue $1.06B, EPS $1.51— 10-Q Summary - TradingView
Align Technology (NASDAQ: ALGN) balances VAT hit with $200M India plant plan - Stock Titan
Align Technology Inc Stock (ALGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Align Technology Inc Stock (ALGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SIEGEL SUSAN E | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
10,723 |
| Saia Andrea Lynn | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
17,318 |
| Poul Mojdeh | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
3,553 |
| Myong Anne | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
9,830 |
| LARKIN C RAYMOND JR | Director |
May 20 '26 |
Option Exercise |
0.00 |
2,326 |
0 |
27,454 |
| Dallas Kevin J | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
16,168 |
| LACOB JOSEPH | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
135,916 |
| Conroy Kevin T | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
3,553 |
| MORROW GEORGE J | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
5,036 |
| Morici John | EVP, CHIEF FINANCIAL OFFICER |
Feb 20 '26 |
Option Exercise |
0.00 |
7,848 |
0 |
16,085 |
2.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):